nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.449	1	CbGbCtD
Cefotaxime—SLC22A8—nephron—focal segmental glomerulosclerosis	0.0591	0.199	CbGeAlD
Cefotaxime—Function kidney decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0393	0.157	CcSEcCtD
Cefotaxime—Traumatic liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.023	0.0918	CcSEcCtD
Cefotaxime—SLC22A11—nephron tubule—focal segmental glomerulosclerosis	0.0226	0.0761	CbGeAlD
Cefotaxime—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.0217	0.0865	CcSEcCtD
Cefotaxime—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.0213	0.0717	CbGeAlD
Cefotaxime—SLC22A11—kidney—focal segmental glomerulosclerosis	0.0199	0.0668	CbGeAlD
Cefotaxime—SLC22A7—kidney—focal segmental glomerulosclerosis	0.0194	0.0652	CbGeAlD
Cefotaxime—SLC22A11—cortex of kidney—focal segmental glomerulosclerosis	0.0193	0.0651	CbGeAlD
Cefotaxime—SLC22A7—cortex of kidney—focal segmental glomerulosclerosis	0.0189	0.0635	CbGeAlD
Cefotaxime—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.0182	0.0613	CbGeAlD
Cefotaxime—SLC15A1—nephron tubule—focal segmental glomerulosclerosis	0.0177	0.0596	CbGeAlD
Cefotaxime—SLC15A1—kidney—focal segmental glomerulosclerosis	0.0156	0.0524	CbGeAlD
Cefotaxime—Nephropathy toxic—Cyclosporine—focal segmental glomerulosclerosis	0.0149	0.0596	CcSEcCtD
Cefotaxime—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0134	0.0533	CcSEcCtD
Cefotaxime—SLC22A8—nephron tubule—focal segmental glomerulosclerosis	0.0127	0.0429	CbGeAlD
Cefotaxime—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.045	CcSEcCtD
Cefotaxime—SLC22A8—kidney—focal segmental glomerulosclerosis	0.0112	0.0377	CbGeAlD
Cefotaxime—SLC15A2—nephron tubule—focal segmental glomerulosclerosis	0.0111	0.0373	CbGeAlD
Cefotaxime—SLC22A8—cortex of kidney—focal segmental glomerulosclerosis	0.0109	0.0367	CbGeAlD
Cefotaxime—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0407	CcSEcCtD
Cefotaxime—SLC15A2—kidney—focal segmental glomerulosclerosis	0.00974	0.0328	CbGeAlD
Cefotaxime—SLC15A2—cortex of kidney—focal segmental glomerulosclerosis	0.00948	0.0319	CbGeAlD
Cefotaxime—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00819	0.0327	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00713	0.0284	CcSEcCtD
Cefotaxime—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00655	0.0261	CcSEcCtD
Cefotaxime—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00652	0.026	CcSEcCtD
Cefotaxime—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.0053	0.0211	CcSEcCtD
Cefotaxime—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00472	0.0188	CcSEcCtD
Cefotaxime—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00468	0.0187	CcSEcCtD
Cefotaxime—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00433	0.0173	CcSEcCtD
Cefotaxime—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00431	0.0172	CcSEcCtD
Cefotaxime—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00431	0.0172	CcSEcCtD
Cefotaxime—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00385	0.0153	CcSEcCtD
Cefotaxime—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.0139	CcSEcCtD
Cefotaxime—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00343	0.0137	CcSEcCtD
Cefotaxime—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.0135	CcSEcCtD
Cefotaxime—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00336	0.0134	CcSEcCtD
Cefotaxime—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00325	0.013	CcSEcCtD
Cefotaxime—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00316	0.0126	CcSEcCtD
Cefotaxime—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.0122	CcSEcCtD
Cefotaxime—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.012	CcSEcCtD
Cefotaxime—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.0104	CcSEcCtD
Cefotaxime—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.0101	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.00998	CcSEcCtD
Cefotaxime—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.0097	CcSEcCtD
Cefotaxime—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00965	CcSEcCtD
Cefotaxime—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00965	CcSEcCtD
Cefotaxime—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.00899	CcSEcCtD
Cefotaxime—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00864	CcSEcCtD
Cefotaxime—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.00835	CcSEcCtD
Cefotaxime—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00776	CcSEcCtD
Cefotaxime—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.0077	CcSEcCtD
Cefotaxime—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00769	CcSEcCtD
Cefotaxime—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00765	CcSEcCtD
Cefotaxime—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00725	CcSEcCtD
Cefotaxime—Cefazolin—ALB—focal segmental glomerulosclerosis	0.000724	0.283	CrCbGaD
Cefotaxime—Ceftriaxone—ALB—focal segmental glomerulosclerosis	0.000686	0.268	CrCbGaD
Cefotaxime—Cefalotin—ALB—focal segmental glomerulosclerosis	0.000601	0.235	CrCbGaD
Cefotaxime—Cephalexin—ALB—focal segmental glomerulosclerosis	0.000546	0.214	CrCbGaD
